$EOLS

Evolus, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Newport Beach, CA

EOLS chart

What traders are saying about $EOLS

Latest posts

Evolus, Inc. news

Evolus, Inc. key financials

USD2025202420232022
Revenue$297.2M$266.3M$202.1M$148.6M
Net income-$51.6M-$50.4M-$61.7M-$74.4M
Diluted EPS$-0.80$-0.81$-1.08$-1.33
Total assets (year end)$225.9M$232.6M$189.0M$178.0M
Cash and equivalents (year end)$53.8M$87.0M$62.8M$53.9M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Evolus, Inc.

Ticker
EOLS (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Newport Beach, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1570562
Former names
Evolus, Inc.

Frequently asked questions

What exchange is Evolus, Inc. listed on?

Evolus, Inc. trades on the Nasdaq under the ticker symbol EOLS.

What industry is Evolus, Inc. in?

Evolus, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Evolus, Inc. headquartered?

Evolus, Inc.'s business address on file with the SEC is in Newport Beach, CA.

When does Evolus, Inc.'s fiscal year end?

Evolus, Inc.'s fiscal year ends on December 31.

How much revenue did Evolus, Inc. report?

Evolus, Inc. reported $297.2M in revenue for calendar year 2025, according to its SEC filings.